Preferences and consequences in therapy decision-making: tiotropium bromide plus olodaterol vs ICS-containing regimens in COPD patients in the Portuguese primary care setting: an observational, cross-sectional study (TIOLCOR Study)First published 16/06/2020 Last updated 01/08/2022 EU PAS number: EUPAS35841StudyPlanned